INGRAM DOUGLAS S has filed 10 insider transactions across 3 companies since May 2023.
Most recent transaction: a grant/award of 7819 shares of ARROWHEAD PHARMACEUTICALS, INC. ($ARWR) on December 16, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | INGRAM DOUGLAS S | Director | A | Common Stock | 7819 | $0.00 | 46,215.0000 | 133,758,000 | 20.36% | 0.01% |
| Dec. 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | INGRAM DOUGLAS S | Chief Executive Officer | A | Common Stock | 50000 | $0.00 | 490,307.0000 | 100,237,000 | 11.36% | 0.05% |
| Dec. 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | INGRAM DOUGLAS S | Chief Executive Officer | A | Common Stock | 50000 | $0.00 | 440,307.0000 | 100,237,000 | 12.81% | 0.05% |
| Dec. 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | INGRAM DOUGLAS S | Chief Executive Officer | A | Common Stock | 73001 | $0.00 | 563,308.0000 | 100,237,000 | 14.89% | 0.07% |
| Dec. 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | INGRAM DOUGLAS S | Chief Executive Officer | A | Common Stock | 96541 | $0.00 | 659,849.0000 | 100,237,000 | 17.14% | 0.10% |
| Dec. 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | INGRAM DOUGLAS S | Chief Executive Officer | A | Common Stock | 269542 | $0.00 | 929,391.0000 | 100,237,000 | 40.85% | 0.27% |
| June 6, 2025 | Relay Therapeutics, Inc. | $RLAY | INGRAM DOUGLAS S | Not found | A | Stock Option (Right to Buy) | 136681 | $0.00 | 136,681.0000 | 169,521,849 | 9999.99% | 0.08% |
| Feb. 6, 2025 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | INGRAM DOUGLAS S | Director | A | Common Stock | 38396 | $20.09 | 38,396.0000 | 124,848,000 | 9999.99% | 0.03% |
| June 3, 2024 | Relay Therapeutics, Inc. | $RLAY | INGRAM DOUGLAS S | Not found | A | Stock Option (Right to Buy) | 102225 | $0.00 | 102,225.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2023 | Relay Therapeutics, Inc. | $RLAY | INGRAM DOUGLAS S | Director | A | Stock Option (Right to Buy) | 66055 | $0.00 | 66,055.0000 | 0 | 9999.99% | 0.00% |